Share on :

Asset Summary

Weekly Performance Report for LABD ETF: Week 47, 2024

Summary: The Weekly started with LABD ETF opening at $7.05 and closing at $6.17. The ETF showed weakness throughout the Weekly, with the highest price observed at $7.36 and the lowest at $6.07. The underlying asset had a trading range of $1.29 Overall, it was a negative trading Weekly for LABD ETF, reflecting investor pessimism and market activity.

Change in Closing Price: There was a net decrease of $-0.88 or -12.48% in the closing price from the opening to the closing price over the Weekly.

Volume Analysis: Trading volume for LABD ETF was 80,547,269 units during Week 47, indicating active market participation and investor interest.

Opening Price: The Weekly started at $7.05.

Highest Price: The highest price observed during the Weekly was $7.36.

Lowest Price: The lowest price observed during the Weekly was $6.07.

Closing Price: The Weekly ended at $6.17.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Optimize Your LABD Trading Now

Take control of your trading with Rankmytrade. Our platform offers unparalleled analysis and technical support for LABD, designed to enhance your market performance. Start optimizing your trades today today and experience the difference with our expert tools!

Explore Insights Now

Frequently Asked Questions

Similar ETFs to LABD include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide 3x the daily performance of the S&P Biotechnology Select Industry Index, the opposite of LABD’s objective; XBI (SPDR S&P Biotech ETF), which provides exposure to the biotechnology sector without leverage; and BIB (Direxion Daily S&P Biotech Bull 2X Shares), which provides 2x the daily performance of the S&P Biotechnology Select Industry Index, less leveraged compared to LABD.

Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.

LABD typically distributes dividends on a quarterly basis. These dividends come from income generated by the underlying securities, although leveraged ETFs like LABD may have lower yields compared to non-leveraged funds.

LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.

Key performance metrics for LABD include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABD targets -3x the daily performance of the S&P Biotechnology Select Industry Index.

Yes, LABD can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it is essential to consider how it fits within your overall investment strategy and risk tolerance.

LABD aims to deliver three times the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index. Over time, due to the effects of compounding and daily rebalancing, its performance may differ significantly from the index.

Investors can buy shares of LABD through a brokerage account. The ETF is traded on major stock exchanges under the ticker symbol "LABD" and can be bought and sold like other stocks and ETFs.

LABD is managed by Direxion Funds and employs leverage through financial instruments such as futures contracts, options, and swap agreements. The fund aims to maintain its -3x leverage ratio through daily rebalancing.

Factors influencing LABD’s performance include movements in the biotech sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. LABD’s daily rebalancing and compounding effects also impact performance.

Maximize Your LABD Trading Now

Achieve superior trading results with Rank My Trade Platform. Our platform provides expert analysis and actionable insights for LABD, utilizing the latest technology to refine your investment approach. Boost your investment success with us now and see the impact on your trading success!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs